Works matching IS 00316970 AND DT 2020 AND VI 76 AND IP 5
Results: 17
Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 723, doi. 10.1007/s00228-020-02848-6
- By:
- Publication type:
- Article
Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 719, doi. 10.1007/s00228-020-02847-7
- By:
- Publication type:
- Article
Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 649, doi. 10.1007/s00228-020-02844-w
- By:
- Publication type:
- Article
Docosahexaenoic acid supplementation in age-related cognitive decline: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 639, doi. 10.1007/s00228-020-02843-x
- By:
- Publication type:
- Article
Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 703, doi. 10.1007/s00228-020-02842-y
- By:
- Publication type:
- Article
Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 695, doi. 10.1007/s00228-020-02840-0
- By:
- Publication type:
- Article
Less is more: a cost benefit analysis of a changed posology for nivolumab.
- Published in:
- 2020
- By:
- Publication type:
- Letter
High-risk medication in community care: a scoping review.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 623, doi. 10.1007/s00228-020-02838-8
- By:
- Publication type:
- Article
Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction – a prospective observational study.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 673, doi. 10.1007/s00228-020-02832-0
- By:
- Publication type:
- Article
Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 711, doi. 10.1007/s00228-020-02830-2
- By:
- Publication type:
- Article
The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 611, doi. 10.1007/s00228-019-02827-6
- By:
- Publication type:
- Article
Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 685, doi. 10.1007/s00228-019-02814-x
- By:
- Publication type:
- Article
Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 659, doi. 10.1007/s00228-019-02803-0
- By:
- Publication type:
- Article